Invasive interventional management of post-hemorrhagic cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage

Journal of NeuroInterventional Surgery

Volumn 4, Issue 3, 2012, Pages 169-177

  Abruzzo, Todd ^a   Moran, Christopher ^b   Blackham, Kristine A ^c   Eskey, Clifford J ^d   Lev, Raisa ^e   Meyers, Philip ^f   Narayanan, Sandra ^g   Prestigiacomo, Charles Joseph ^h  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^e Aurora Baycare Medical Center Clinic   (United States)

^f Columbia University ^*  (United States)

^g WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPERTENSIVE FACTOR; MILRINONE; NICARDIPINE; NIMODIPINE; PAPAVERINE; VASODILATOR AGENT; VERAPAMIL;

BRAIN CIRCULATION; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN VASOSPASM; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; DISEASE MODEL; DISEASE SEVERITY; DRUG MEGADOSE; EVIDENCE BASED MEDICINE; HEMODYNAMICS; HUMAN; HYPOTENSION; INVASIVE PROCEDURE; NONHUMAN; POST HEMORRHAGIC CEREBRAL VASOSPASM; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SAFETY; SUBARACHNOID HEMORRHAGE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT INDICATION; VASOCONSTRICTION;

ANGIOPLASTY, BALLOON; HUMANS; INFUSIONS, INTRA-ARTERIAL; NEUROSURGICAL PROCEDURES; REFERENCE STANDARDS; SUBARACHNOID HEMORRHAGE; VASODILATOR AGENTS; VASOSPASM, INTRACRANIAL;

EID: 84860756487     PISSN: 17598478     EISSN: 17598486     Source Type: Journal    
DOI: 10.1136/neurintsurg-2011-010248     Document Type: Review

References (71)

1. Egge A, Waterloo K, Sjoholm H, et al. Prophylactic hyperdynamic postoperative fluid therapy after aneurismal subarachnoid hemorrhage: a clinical, prospective, randomized, controlled study. Neurosurgery 2001;49:593-605.
2. Turjman J, Mimon S, Yilmaz H. Epidemiology, clinical study and pathology of vasospasm. J Neuroradiol 1999;26:S10-16.
3. Crowley RW, Medel R, Dumont AS, et al. Angiographic vasospasm is strongly correlated with cerebral infarction after subarachnoid hemorrhage. Stroke 2011;42:919-23.
4. Vergouwen MDI, Ilodigwe D, Macdonald RL. Cerebral infarction after subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and -independent effects. Stroke 2011;42:924-9.
5. Clark JF, Sharp FR. Bilirubin oxidation products (BOXes) and their role in cerebral vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab 2006;26:1223-33. (Pubitemid 44435238)
6. Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980;6:1-9. (Pubitemid 10159923)
7. Kistler JP, Crowell RM, Davis KR, et al. The relation of cerebral vasospasm to the extent and location of subarachnoid blood. Neurology 1983;33:424-36.
8. Heros RC, Zervas NT, Varsos V. Cerebral vasospasm after subarachnoid hemorrhage: an update. Ann Neurol 1983;14:599-608. (Pubitemid 14211605)
9. Kassell NF, Sasaki T, Colohan AR, et al. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 1985;16:562-72. (Pubitemid 15007226)
10. Zabramski JM, Hamilton MG. Cerebral vasospasm. In: Carter LP, Spetzler RF, Hamilton MG, eds. Neurovascular surgery. New York: McGraw Hill, 1995:583-601.
11. Meyers PM, Schumacher HC, Higashida RT, et al. Indications for the performance of intra-cranial endovascular neurointerventional procedures: a scientific statement from the American Heart Association Council on Cardiovascular Radiology and Intervention, Stroke Council, Council on Cardiovascular Surgery and Anesthesia, Interdisciplinary Council on Peripheral Vascular Disease and Interdisciplinary Council on Quality of Care and Outcomes Research. Circulation 2009;119: 2235-49.
12. Bederson JB, Connolly ES, Batjer HH, et al. Guidelines for the management of aneurismal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 2009;40:994-1025.
13. Megyesi JF, Findlay JM, Vollrath B, et al. In vivo angioplasty prevents the development of vasospasm in canine carotid arteries. Pharmacological and morphological analyses. Stroke 1997;28:1216-24. (Pubitemid 27248900)
14. Muizelaar JP, Zwienenberg M, Rudisill RN, et al. The prophylactic use of transluminal balloon angioplasty in patients with Fisher Grade 3 subarachnoid hemorrhage: a pilot study. J Neurosurg 1999;91:51-8.
15. Zwienenberg-Lee M, Hartman J, Rudisill N, et al; for The Balloon Prophylaxis for Aneurysmal Vasospasm (BPAV) Study Group. Effect of prophylactic transluminal balloon angioplasty on cerebral vasospasm and outcome in patients with Fisher Grade III subarachnoid hemorrhage: results of a Phase II multicenter, randomized, clinical trial. Stroke 2009;39:1759-65.
16. Diringer MN, Bleck TP, Hemphill JC, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care 2011;15:211-40.
17. Kassell NF, Peerless SJ, Durward QJ, et al. Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 1982;3:337-43. (Pubitemid 12019403)
18. Platz J, Guresir E, Vatter H, et al. Unsecured intracranial aneurysms and induced hypertension in cerebral vasospasm: is induced hypertension safe? Neurocrit Care 2011;14:168-75.
19. Kimball MW, Velat GJ, Hoh BL; The participants in the international mult-disciplinary consensus conference on the critical care management of subarachnoid hemorrhage. Critical care guidelines on the endovascular management of cerebral vasospasm. Neurocrit Care 2011;14:336-41.
20. Rosenwasser RH, Armonda RA, Thomas JE, et al. Therapeutic modalities for the management of cerebral vasospasm: timing of endovascular options. Neurosurgery 1999;44:975-80. (Pubitemid 29202857)
21. Wintermark M, Dillon WP, Smith WS, et al. Visual grading system for vasospasm based on perfusion CT imaging: Comparisons with conventional angiography and quantitative perfusion CT. Cerebrovasc Dis 2008;26:163-70.
22. Lylyk P, Vila JF, Miranda C, et al. Partial aortic obstruction improves cerebral perfusion and clinical symptoms in patients with symptomatic vasospasm. Neurol Res 2005;27(Suppl 1):S129-35. (Pubitemid 41510943)
23. Eskridge JM, McAuliffe W, Song JK, et al. Balloon angioplasty for the treatment of vasospasm: results of first 50 cases. Neurosurgery 1998;42:510-17. (Pubitemid 28128736)
24. Eskridge JM, Song JK. A practical approach to the treatment of vasospasm. AJNR Am J Neuroradiol 1997;18:1653-60. (Pubitemid 30399764)
25. Zubkov YN, Nififorov BM, Shustin VA. Balloon catheter technique for dilatation of constricted cerebral arteries after aneurismal SAH. Acta Neurochir 1984;70:65-79. (Pubitemid 14191588)
26. Terry A, Zipfel G, Milner E, et al. Safety and technical efficacy of over-the-wire balloons for the treatment of subarachnoid hemorrhage induced cerebral vasospasm. Neurosurg Focus 2006;21:1-7.
27. Yamamoto Y, Smith RR, Bernanke DH. Mechanism of action of balloon angioplasty in cerebral vasospasm. Neurosurgery 1992;30:1-6.
28. Voldby B, Enevoldsen EM, Jensen FT. Cerebrovascular reactivity in patients with ruptured intracranial aneurysms. J Neurosurg 1985;62:59-67. (Pubitemid 15199404)
29. Shimizu K, Ohta T, Toda N. Evidence for greater susceptibility of isolated dog cerebral arteries to calcium antagonists than peripheral arteries. Stroke 1980;11:261-6. (Pubitemid 10112983)
30. Feng L, Fitzsimmons B, Young W. Intra-arterially administered verapamil as adjunct therapy for cerebral vasospasm: safety and a two year experience. AJNR Am J Neuroradiol 2002;23:1284-90. (Pubitemid 35033874)
31. Mazumdar A, Rivet DJ, Derdeyn CP, et al. Effect of intra-arterial verapamil on the diameter of vasospastic intracranial arteries in patients with cerebral vasospasm. Neurosurg Focus 2006;21:E15.
32. Stuart RM, Helbok R, Kurtz M, et al. High-dose intra-arterial verapamil for the treatment of cerebral vasospasm: prolonged effects on hemodynamic parameters and brain metabolism. Neurosurgery 2011;68:337-45.
33. Binaghi S, Colleoni ML, Maeder P, et al. CT angiography and perfusion CT in cerebral vasospasm after subarachnoid hemorrhage. AJNR Am J Neuroradiol 2007;28:750-8. (Pubitemid 46608619)
34. Andaluz N, Tomsick TA, Tew JM, et al. Indications for endovascular therapy for refractory vasospasm after aneurysmal subarachnoid hemorrhage: experience at the University of Cincinnati. Surg Neurol 2002;58:131-8. (Pubitemid 35365913)
35. Cross DT III, Moran CJ, Angtuaco EE, et al. Intracranial pressure monitoring during intra-arterial papaverine infusion for cerebral vasospasm. AJNR Am J Neuroradiol 1998;19:1319-23. (Pubitemid 30418681)
36. Rosenberg N, Lazzaro MA, Lopes DK, et al. High-dose intra-arterial nicardipine results in hypotension following vasospasm treatment in subarachnoid hemorrhage. Neurocrit Care 2011;15:400-4.
37. Santillan A, Knopman J, Zink W, et al. Transluminal balloon angioplasty for symptomatic distal vasospasm refractory to medical therapy in patients with aneurismal subarachnoid hemorrhage. Neurosurgery 2011;69:95-102.
38. Newell DW, Eskridge JM, Aaslid R. Current indications and results of cerebral angioplasty. Acta Neurochir Suppl 2001;77:181-3. (Pubitemid 33759243)
39. Higashida RT, Halbach VV, Cahan LD, et al. Transluminal angioplasty for treatment of intracranial arterial vasospasm. J Neurosurg 1989;71:648-53. (Pubitemid 19275760)
40. Hoh BL, Ogilvy CS. Endovascular treatment of cerebral vasospasm: transluminal balloon angioplasty, intra-arterial papaverine, and intra-arterial nicardipine. Neurosurg Clin N Am 2005;16:501-16. (Pubitemid 41766378)
41. Merchant A, Drazin D, Dalfino J, et al. Delayed stenosis as a consequence of angioplasty for subarachnoid hemorrhage-induced vasospasm. Case report. Neurosurg Focus 2009;26:E23.
42. Smith WS, Dowd CF, Johnston C, et al. Neurotoxicity of intra-arterial papaverine preserved with chlorobutanol used for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 2004;35:2518-22. (Pubitemid 39458410)
43. Mathis JM, Jensen ME, Dion JE. Technical considerations on intra-arterial papaverine hydrochloride for cerebral vasospasm. Neuroradiology 1997;39:90-8. (Pubitemid 27075455)
44. Fraicelli AT, Cholley BP, Losser MR, et al. Milrinone for the treatment of cerebral vasospasm after aneurismal subarachnoid hemorrhage. Stroke 2008;39:893-8. (Pubitemid 351619546)
45. Albanese E, Russo A, Quiroga M, et al. Ultra-high dose intra-arterial infusion of verapamil through an indwelling microcatheter for medically refractory severe vasospasm: initial experience. J Neurosurg 2010;113:913-22.
46. Avitsian R, Fiorella D, Soliman MM, et al. Anesthetic considerations of selective intra-arterial nicardipine injection for intracranial vasospasm: a case series. J Neurosurg Anesthesiol 2007;19:125-9. (Pubitemid 46596681)
47. Tejada JG, Taylor RA, Ugurel MS, et al. Safety and feasibility of intra-arterial nicardipine for the treatment of subarachnoid hemorrhage-associated vasospasm: initial clinical experience with high-dose infusions. AJNR Am J Neuroradiol 2007;28:844-8. (Pubitemid 46776059)
48. Platz J, Berkefeld J, Guresir E, et al. Interim Analysis of a Prospective Randomized Trial to Investigate the Efficacy of Endovascular Treatment in Cerebral Vasospasm after Subarachnoid Hemorrhage. 11th Annual International Conference on Neurovascular Events after Subarachnoid Hemorrhage; July 21 e 23, 2011, Cincinnati, Ohio (abstract).
49. Fujii Y, Takahashi A, Yoshimoto T. Effect of balloon angioplasty on high grade symptomatic vasospasm after subarachnoid hemorrhage. Neurosurg Rev 1995;18:7-13.
50. Murayama Y, Song JK, Uda K, et al. Combined endovascular treatment for both intracranial aneurysm and symptomatic vasospasm. AJNR Am J Neuroradiol 2003;24:133-9. (Pubitemid 36110116)
51. Polin RS, Coenen VA, Apperson Hansen C, et al. Efficacy of transluminal angioplasty for the management of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 2000;92:284-90. (Pubitemid 30071048)
52. Elliott JP, Newell DW, Lam DJ, et al. Comparison of balloon angioplasty and papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 1998;88:277-84. (Pubitemid 28063601)
53. Firlik KS, Kaufmann AM, Firlik AD, et al. Intra-arterial papaverine for the treatment of cerebral vasospasm following aneurismal subarachnoid hemorrhage. Surg Neurol 1999;51:66-74. (Pubitemid 29056791)
54. Newell DW, Eskridge JM, Mayberg MR, et al. Angioplasty for the treatment of symptomatic vasospasm following subarachnoid hemorrhage. J Neurosurg 1989;71:654-60. (Pubitemid 19275761)
55. Bejjani GK, Bank WO, Olan WJ, et al. The efficacy and safety of angioplasty for cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery 1998;42:979-87. (Pubitemid 28196508)
56. Coyne TJ, Montanera WJ, Macdonald RL, et al. Percutaneous transluminal angioplasty for cerebral vasospasm after subarachnoid hemorrhage. Can J Surg 1994;37:391-6. (Pubitemid 24358546)
57. Clouston JE, Numaguchi Y, Zoarski GH, et al. Intraarterial papaverine infusion for cerebral vasospasm after subarachnoid hemorrhage. AJNR Am J Neuroradiol 1995;16:27-38.
58. Kaku Y, Yonekawa Y, Tsukahara T, et al. Super selective intra-arterial infusion of papaverine for the treatment of cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 1992;77:842-7.
59. Kassell NF, Helm G, Simmons N, et al. Treatment of cerebral vasospasm with intraarterial papaverine. J Neurosurg 1992;77:848-52.
60. Firlik AD, Kaufmann AM, Jungreis CA, et al. Effect of transluminal angioplasty on cerebral blood flow in the management of symptomatic vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 1997;86:830-9. (Pubitemid 27187686)
61. Polin RS, Hansen CA, German P, et al. Intra-arterially administered papaverine for the treatment of symptomatic cerebral vasospasm. Neurosurgery 1998;42:1256-64.
62. Arakawa Y, Kikuta K, Hojo M, et al. Milrinone for the treatment of cerebral vasospasm after subarachnoid hemorrhage: report of seven cases. Neurosurgery 2001;48:723-30. (Pubitemid 32268081)
63. Biondi A, Ricciardi G, Puybasset L. Intra-arterial nimodipine for the treatment of symptomatic cerebral vasospasm after aneurismal subarachnoid hemorrhage. AJNR Am J Neuroradiol 2004;25:1067-76. (Pubitemid 38765893)
64. Sehy JV, Holloway WE, Lin SP, et al. Improvement in angiographic cerebral vasospasm after intra-arterial verapamil administration. AJNR Am J Neuroradiol 2010;31:1923-8.
65. Badjatia N, Topcuoglu MA, Pryor JC, et al. Preliminary experience with intra-arterial nicardipine as a treatment for cerebral vasospasm. AJNR Am J Neuroradiol 2004;25:819-26. (Pubitemid 38657670)
66. Vergouwen MDI, Vermeulen M, Gijn JV, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: Proposal of a multidisciplinary research group. Stroke 2010;41:2391-5.
67. Macdonald RL, Higashida RT, Keller E, et al. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid hemorrhage undergoing clipping: a randomized, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2).Lancet Neurol 2011;10:618-25.
68. Coenen VA, Apperson Hansen C, Kassell NF, et al. Endovascular treatment for symptomatic cerebral vasospasm after subarachnoid hemorrhage: transluminal balloon angioplasty compared with intraarterial papaverine. Neurosurg Focus 1998;5:E6.
69. Oskouian RJ, Martin NA, Lee JH, et al. Multimodal quantitation of the effects of endovascular therapy for vasospasm on cerebral blood flow, transcranial Doppler ultrasonic velocities, and cerebral artery diameters. Neurosurgery 2002;51:30-43. (Pubitemid 36331097)
70. Rabinstein AA, Friedman JA, Nichols DA, et al. Predictors of outcome after endovascular treatment of cerebral vasospasm. AJNR Am J Neuroradiol 2004;25:1778-82. (Pubitemid 44123705)
71. Terada T, Kinoshita Y, Yokote H, et al. The effect of endovascular therapy for cerebral artery spasm, its limitaions and pitfalls. Acta Neurochirurg 1997;139:227-34. (Pubitemid 27144066)